To Charge or Not to Charge: Pricing Health Products in Northern Uganda
How to cite
Karlan, Dean; Raffler, Pia; McConnell, Margaret; Fischer, Greg. 2016. "To Charge or Not to Charge: Pricing Health Products in Northern Uganda." AEA RCT Registry. AEARCTR-0001414. https://doi.org/10.1257/rct.1414-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
In a field experiment in Uganda, a free distribution of three health products lowers subsequent demand relative to a sale distribution. This contrasts with work on insecticide-treated bed nets, highlighting the importance of product characteristics in determining pricing policy. We put forward a model to illustrate the potential tension between two of these important factors, learning and anchoring, and then test this model with three products selected specifically for their variation in the scope for learning. We find the rank order of percentage change of shifts in demand matches theoretical predictions, although the differences are not statistically significant, and only two of three pairwise comparisons match when the reductions are specified in percent terms. These results highlight the importance of understanding pricing policy with respect to product, market, and household characteristics.
Experimental design
This project sought to evaluate the tension between two important factors, learning and anchoring, in determining the demand for health products in less-developed countries, and help settle the debate in the development aid community over the pricing of these products. A field experiment in northern Uganda was designed where health products were distributed door-to-door either for free or for sale at market prices. Three products were offered that differed in their scope for learning: Panadol, a pain reliever widely known to consumers and for which no scope for learning was expected; Elyzole, a deworming drug that was moderately well-known and for which negative learning due to side effects was expected; and Zinkid, an improved treatment for childhood diarrhea that was largely unknown and for which positive learning was expected. Approximately ten weeks after the initial distribution, representatives from an unrelated, for-profit firm offered the households either the same or a new health product for sale at market prices. The key outcome measure is households’ purchase decisions in this second distribution.
Design details
Papers from this trial
- Fischer, Greg, Dean Karlan, Margaret McConnell, and Pia Raffler. “To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda. Working Paper June 2016. https://www.povertyactionlab.org/sites/default/files/publications/477_544_To%20charge%20or%20not%20Charge_Greg%26Dean%26Margaret%26Pia_June2016.pdf
Cited by
No citation data available for this registration yet.